Update on the End-Stage Renal Disease Quality Incentive Program
Rimda Wanchoo1, Azzour D Hazzan1, Steven Fishbane1
1SB Hofstra Northwell School of Medicine, Division of Nephrology, Department of Medicine, Great Neck, New York.
Abstract:
The End-Stage Renal Disease Quality Incentive Program continues to evolve and expand. In this article, we will review the program's structure and critically assess the clinical metrics in place. In addition, we will discuss upcoming program changes to help prepare dialysis facilities and nephrologists to meet new proposed metrics.
Related Concept Videos
Chronic Kidney Disease III: Interprofessional Care
Acute Kidney Injury I: Introduction
Continuous Renal Replacement Therapy
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate
Chronic Kidney Disease I: Introduction
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy


